The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Residual risk assessment with the Breast Cancer Index (BCI) for prediction of late distant recurrence (DR) in patients from the TransATAC study.
 
Ivana Sestak
Honoraria - Myriad Genetics; NanoString Technologies
Consulting or Advisory Role - Myriad Genetics
 
Yi Zhang
Employment - bioTheranostics
 
Dennis Sgroi
No Relationships to Disclose
 
Catherine A. Schnabel
Employment - Biotheranostics
Leadership - Biotheranostics
Stock and Other Ownership Interests - Biotheranostics
 
Jack M. Cuzick
Consulting or Advisory Role - Atossa Genetics; Cancer Prevention Pharmaceuticals; Merck; Mycology; Qiagen; Roche
Speakers' Bureau - Becton Dickinson; Gen-Probe; Hologic
Research Funding - AstraZeneca (Inst); Aventis Pharma (Inst); Becton Dickinson (Inst); Genera Biosystems (Inst); Myriad Genetics (Inst); Qiagen (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Myriad Geneticsto institution of which I receive a share for development of Cell cycle progression score (Prolaris)
 
Mitchell Dowsett
Honoraria - Myriad Genetics; Novartis; Pfizer
Consulting or Advisory Role - Genoptix; GTx; Janssen Oncology; Radius Health; Roche/Genentech
Research Funding - AstraZeneca (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Roche (Inst)
Other Relationship - Institute of Cancer Research